openPR Logo
Press release

Preclinical In-vivo Imaging Industry to Witness Massive Growth (2024-2031) | Siemens A.G, TriFoil Imaging, PerkinElmer, VisualSonics Inc. (Fujifilm), MILabs B.V

08-30-2024 10:33 AM CET | Health & Medicine

Press release from: DataM intelligence 4 Market Research LLP

Preclinical In-vivo Imaging Industry to Witness Massive Growth

Preclinical In-vivo Imaging Industry Analysis, according DataM Intelligence. Although data provides an overview, the research explores the hidden aspects of the sector, breaking down its intricate dynamics, charting regional dominance, spotting demand patterns, and spotting prospective breakthroughs that could influence how businesses operate in the future.

Will the Preclinical In-vivo Imaging market emerge as the sector's next great thing? To discover the answer, look at the Preclinical In-vivo Imaging market analysis and projections. In-depth insight of the opportunities, difficulties, and trends now impacting the Machinery landscape is provided by this market research study, empowering industry participants to make informed decisions in a changing environment. Take advantage of the opportunity in the Preclinical In-vivo Imaging market! (2031)

Get a Free Sample Research PDF - https://datamintelligence.com/download-sample/preclinical-in-vivo-imaging-market

Key Growth Drivers in Preclinical In-vivo Imaging Market:

The global preclinical in-vivo imaging market is growing due to advancements in molecular imaging technology, increased interest in non-invasive small animal imaging, and a rise in preclinical research funding from public and private sectors. North America holds the largest share of the global market, with the United States leading in this region.

DataM Intelligence profiles some of the most reputed organizations present in the Preclinical In-vivo Imaging market. They are as follows:

Siemens A.G, TriFoil Imaging, PerkinElmer, VisualSonics Inc. (Fujifilm), MILabs B.V, Mediso Ltd and Agilent Technologies.

Segment Covered in the Preclinical In-vivo Imaging Market:

By Modality: Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-MRI Systems, Micro-Ultrasound Systems, Micro-CT Systems, Preclinical Photoacoustic Imaging Systems, Preclinical Magnetic Particle Imaging (MPI) Systems

By Reagent: Preclinical Optical Imaging Reagents, Preclinical Nuclear Imaging Reagents, Preclinical MRI Contrast Agents, Preclinical Ultrasound Contrast Agents, Preclinical CT contrast agents

By Application: Research and development, Drug discovery

By Distribution Channel: Pharmaceutical companies, Biotechnology companies, Research institutes, Others

Regional Analysis:

The global Preclinical In-vivo Imaging Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa.

Get Customization in the report as per your requierments: https://datamintelligence.com/customize/preclinical-in-vivo-imaging-market

Regional Analysis:

The global Preclinical In-vivo Imaging Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The Preclinical In-vivo Imaging Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.

Chapter Outline:

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: key insights, key emerging trends, etc.

Chapter 3: Manufacturers competitive analysis, detailed analysis of Preclinical In-vivo Imaging manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 5 & 6: Revenue of Preclinical In-vivo Imaging in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: The main points and conclusions of the report.

Get a Free Sample PDF copy of the report @ https://datamintelligence.com/download-sample/preclinical-in-vivo-imaging-market

FAQ's

Q.1. What are the primary drivers of the Preclinical In-vivo Imaging Industry?

Q.2. What are the main factors propelling and impeding the growth of the Preclinical In-vivo Imaging market?

Q.3. What are the general structure, risks, and opportunities of the market?

Q.4. How do the prices, revenue, and sales of the leading Preclinical In-vivo Imaging market firms compare?

Q.5. What are the main segments of the market and how is it divided up?

Q.6. Which companies dominate the market, and what percentage of the market do they control?

Q.7. What trends are influencing the Preclinical In-vivo Imaging market now and in the future?

Read Latest Blog: https://www.datamintelligence.com/blogs/top-10-process-automation-companies-worldwide

Affiliate Marketing Request here: https://www.datamintelligence.com/affiliate-marketing

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Preclinical In-vivo Imaging Industry to Witness Massive Growth (2024-2031) | Siemens A.G, TriFoil Imaging, PerkinElmer, VisualSonics Inc. (Fujifilm), MILabs B.V here

News-ID: 3640280 • Views:

More Releases from DataM intelligence 4 Market Research LLP

United States Immunohistochemistry Market 2026 | Growth Drivers, Trends & Market Forecast, Competitive Landscape & Investment Opportunities
United States Immunohistochemistry Market 2026 | Growth Drivers, Trends & Market …
Market Size and Growth The Global Immunohistochemistry Market size was valued at US$ 2,302.79 million in 2022 and is estimated to reach US$4,240.65 million by 2031, growing at a CAGR of 8.1% during the forecast period (2024-2031). Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/immunohistochemistry-market?sb Key Development: United States: Recent Industry Developments ✅ In February 2026, the U.S. Food and Drug Administration approved PD‐L1 IHC 22C3 pharmDx
Critical Minerals Market to Reach US$ 586.63 Billion by 2032; Asia Pacific Leads with 35% Share | Key Players: Albemarle Corporation, China Northern Rare Earth, MP Materials
Critical Minerals Market to Reach US$ 586.63 Billion by 2032; Asia Pacific Leads …
Market Overview Market Size (2024): USD 328.19 billion Expected Market Size (2032): USD 586.63 billion CAGR (2025-2032): 7.53% The global critical minerals market is experiencing unprecedented growth, driven primarily by the accelerating transition to clean energy technologies. Key energy transition minerals including lithium, cobalt, and nickel have seen rapid demand growth: lithium demand has tripled, cobalt demand has risen by 70%, and nickel demand has increased by 40% between 2017 and 2022. Clean energy
Drug of Abuse Testing Market to Reach US$ 12.31 Billion by 2033; North America Leads with 40% Share | Key Players: Siemens Healthcare, Thermo Fisher Scientific, Abbott
Drug of Abuse Testing Market to Reach US$ 12.31 Billion by 2033; North America L …
Market Overview Market Size (2023): USD 7.26 billion Expected Market Size (2033): USD 12.31 billion CAGR (2025-2033): 5.3% Drug abuse testing is a critical process for detecting prescription and illicit substances in an individual's system, ensuring safety, regulatory compliance, and medical evaluation. It is widely used across workplace screening, forensic investigations, sports anti-doping programs, and clinical diagnostics. Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):-https://www.datamintelligence.com/download-sample/drug-of-abuse-testing-market?Juli Advancements in rapid detection
United States Aesthetic Lasers and Energy Devices Market 2026 | Growth Drivers, Trends & Market Forecast, Competitive Landscape & Investment Opportunities
United States Aesthetic Lasers and Energy Devices Market 2026 | Growth Drivers, …
Market Size and Growth Aesthetic Lasers and Energy Devices Market is estimated to reach at a CAGR of 6.40% during the forecast period (2024-2031). Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/aesthetic-lasers-and-energy-devices-market?sb Key Development: United States: Recent Industry Developments ✅ In November 2025, Venus Concept Inc. secured FDA 510(k) clearance for its Venus NOVATM platform, a next‐generation multi‐application device combining radiofrequency, EMS, and electromagnetic technologies for non‐invasive

All 5 Releases


More Releases for Preclinical

Rising Chronic Disease Burden Fuels Preclinical Imaging Market Growth Emerges as …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Preclinical Imaging Market Through 2025? In the past few years, the preclinical imaging market has witnessed a significant increase in its size. The market is projected to surge from $3.46 billion in 2024 to $3.69 billion in 2025, recording a compound annual
Driving Preclinical CRO Market Growth in 2025: The Role of Surging Demand For Pr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Preclinical CRO Market Size Growth Forecast: What to Expect by 2025? In recent times, there has been a significant increase in the size of the preclinical CRO market. The market will develop from being worth $5.7 billion in 2024 to achieving a value of $6.26 billion the following year,
DLL3 Inhibitors in Preclinical and Clinical Studies
Delta-Like Ligand 3 (DLL3) inhibitors have shown significant promise in preclinical and clinical studies, particularly for the treatment of aggressive cancers such as small cell lung cancer (SCLC) and neuroendocrine tumors. The selective expression of DLL3 in these malignancies makes it an attractive target for therapeutic intervention. This article explores the development and progress of DLL3 inhibitors in preclinical and clinical studies, highlighting their potential in modern oncology. Download Report: https://www.kuickresearch.com/report-dll3-targeted-therapies-dll3-cancer-therapies-dll3-protien-dll3-cancer-drugs-delta-like-ligand-3-dll3-gene-dll3-expression-dll3-amgen-dll3-inhibitor DLL3
Preclinical Imaging Market Opportunity | Size | Research Report
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲-  Preclinical Imaging Market was valued at USD 748.18 Million in 2023 and is projected to reach USD 1,109.10 Million by 2030, growing at a CAGR of 5.0% from 2024 to 2030. The preclinical imaging market is being significantly driven by advancements in imaging modalities, such as MRI, PET, SPECT, CT, and optical imaging. These technologies provide researchers with non-invasive ways to visualize and study biological processes at the
Preclinical Imaging Market - Transforming Research with Precision Imaging: Precl …
Newark, New Castle, USA: The "Preclinical Imaging Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Preclinical Imaging Market: https://www.growthplusreports.com/report/preclinical-imaging-market/7673 This latest report researches the industry structure, sales, revenue,
Preclinical Imaging Market - Unlocking Clarity, Preserving Scientific Excellence …
Newark, New Castle, USA - new report, titled Preclinical Imaging Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Preclinical Imaging market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Preclinical Imaging market. The report offers an overview of the market, which